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Abstract
Background: We previously showed that irradiation to the carotid arteries of ApoE
2/2 mice accelerated the development of
macrophage-rich, inflammatory atherosclerotic lesions, prone to intra-plaque hemorrhage. In this study we investigated the
potential of anti-inflammatory and anti-coagulant intervention strategies to inhibit age-related and radiation-induced
atherosclerosis.
Methodology/Principal Findings: ApoE
2/2 mice were given 0 or 14 Gy to the neck and the carotid arteries and aortic
arches were harvested at 4 or 30 weeks after irradiation. Nitric oxide releasing aspirin (NCX 4016, 60 mg/kg/day) or aspirin
(ASA, 30 or 300 mg/kg/day) were given continuously in the chow. High dose ASA effectively blocked platelet aggregation,
while the low dose ASA or NCX 4016 had no significant effect on platelet aggregation. High dose ASA, but not NCX 4016,
inhibited endothelial cell expression of VCAM-1 and thrombomodulin in the carotid arteries at 4 weeks after irradiation;
eNOS and ICAM-1 levels were unchanged. After 30 weeks of follow-up, NCX 4016 significantly reduced the total number of
lesions and the number of initial macrophage-rich lesions in the carotid arteries of unirradiated mice, but these effects were
not seen in the brachiocephalic artery of the aortic arch (BCA). In contrast, high dose ASA lead to a decrease in the number
of initial lesions in the BCA, but not in the carotid artery. Both high dose ASA and NCX 4016 reduced the collagen content of
advanced lesions and increased the total plaque burden in the BCA of unirradiated mice. At 30 weeks after irradiation,
neither NCX 4016 nor ASA significantly influenced the number or distribution of lesions, but high dose ASA lead to
formation of collagen-rich ‘‘stable’’ advanced lesions in carotid arteries. The total plaque area of the irradiated BCA was
increased after ASA, but the plaque burden was very low compared with the carotid artery.
Conclusions/Significance: The development and characteristics of radiation-induced atherosclerosis varied between
different arteries but could not be circumvented by anti-inflammatory and anti-coagulant therapies. This implicates other
underlying mechanistic pathways compared to age-related atherosclerosis.
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Introduction
The long-term survival of cancer patients is improving due to
earlier diagnosis and better treatment. However, this results in an
increased number of patients at risk for developing late side effects.
In 2002, the total number of recorded cancer survivors in the
world was estimated to be just under 25 million and in 2025 this
number will approach 50 million [1]. At least half of these patients
will have received radiotherapy. Early and late side effects limit
radiation dose and have significant impact in terms of both quality
of life and overall survival. Whereas typical side effects are systemic
in the case of drug therapies, they are local or loco-regional in
irradiated patients. Cardiovascular and cerebrovascular diseases
are known complications of radiotherapy for many types of
cancer, including head and neck, breast and Hodgkin’s lymphoma
[2–4]. There is good evidence to identify radiation as an
independent risk factor in human vascular disease, in addition to
the classical risk factors like hypercholesterolemia, age, diabetes,
hypertension, smoking, stress and lack of exercise. Several studies
have shown that irradiation of the carotid arteries leads to
development of atherosclerosis, which increases the risk of vascular
stenosis, thromboembolism and stroke [2,5,6].
We have shown in previous studies that both fractionated
irradiation and high single dose irradiation to the carotid arteries
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deficient (ApoE
2/2) mice and predispose to the formation of an
inflammatory, prothrombotic plaque phenotype [7,8]. Other
experimental studies in hypercholesterolemic rabbits or mice fed
high fat diets have also demonstrated that single dose irradiation of
large arteries results in an accelerated formation of atherosclerotic
plaques [9,10].
Inflammation has been shown to both initiate and maintain the
formation of atherosclerosis in coronary and peripheral arteries.
One of the earliest events in the development of atherosclerotic
lesions is the accumulation of monocytes/macrophages and
lymphocytes in the intima of large vessels, which is mediated by
distinct endothelial cell adhesion molecules like Intracellular
Adhesion Molecule-1 (ICAM-1), Vascular Cell Adhesion Mole-
cule-1 (VCAM-1) and selectins [11,12]. Platelets play an important
role in vascular inflammation and initiation of atherosclerosis,
through release of their own pro-inflammatory mediators and
close interaction with other cell types (endothelial cells, leukocytes
and smooth muscle cells) [13].
Acetylsalicylic acid (ASA), an anti-platelet drug, is recommend-
ed and prescribed in the prevention of vascular events in a variety
of clinical conditions, such as myocardial infarction, thrombosis
and stroke [14,15]. Its beneficial effect is not only by blocking
platelets’ ability to aggregate, but also by other mechanisms, such
as preventing thromboxane A2 (TxA2)-induced vasoconstriction
and reducing inflammation. A major limitation to long term ASA
therapy is the risk of gastrointestinal events such as ulceration and
bleeding due to the reduced mucosal production of COX-1
derived cytoprotective prostaglandins [16]. An approach to reduce
the gastric damaging effects of ASA is to create a new molecule in
which the acetylsalicylic moiety is chemically linked to a nitric
oxide (NO)-donating group. The compound used in this study is
NCX 4016 (previously called NO-ASA) that has been shown to
possess at least the same anti-inflammatory activity as ASA, but
with a sparing action on the gastric mucosa of animals and
humans [17,18]. In addition, NCX 4016 has been shown to be
more effective than ASA in preventing neointimal remodeling and
reducing inflammatory cell invasion and stenosis after arterial
injury in hypercholesterolemic mice [19,20].
Since inflammatory and thrombotic events are dominant
features in radiation-induced atherosclerosis, we hypothesized that
anti-inflammatory and anti-thrombotic agents should prevent or
ameliorate radiation-induced atherosclerosis. Therefore, we ex-
amined the effects of ASA and NCX 4016 on the development of
radiation-induced atherosclerosis and compared this with age-
related atherosclerosis in ApoE
2/2 mice.
Results
Evaluation of systemic effects
We observed an increase in body weight during the 30 week
follow-up period in all mice, but irradiated mice gained less weight
than unirradiated mice. In the unirradiated group, mice given
NCX 4016 or ASA containing chow gained less weight than mice
given control chow, but this difference was not seen in the
irradiated mice (Table 1). No significant differences in food intake
between treatment groups were found (Table 1). The measured
food intake is a slight overestimation as spillage was not measured.
At the end of the study all treatment groups had comparable total
cholesterol levels. Small differences were seen between groups in
HDL and triglyceride levels, but this seems not to be due to
irradiation or treatment with NCX 4016 or ASA (Table 1).
There was an almost complete inhibition of platelet aggrega-
tion, measured ex vivo after triggering with arachidonic acid in
mice treated with high dose ASA. Treatment with NCX 4016 or
low dose ASA did not inhibit platelet aggregation and irradiation
had no influence on platelet aggregation (Figure 1).
Effect of NCX 4016 and ASA on age-related
atherosclerosis
To examine whether NCX 4016 and high dose ASA were able
to reduce age-related atherosclerosis, mice were sacrificed 30
weeks after start of the treatment and the number of lesions and
the total plaque area in both carotid arteries or the brachioce-
phalic artery of the aortic arch (BCA) were determined. All mice
developed atherosclerosis with age. Treatment with NCX 4016
resulted in a significant decrease in the total number of lesions
(p=0.04) and number of initial lesions (p=0.02) in carotid arteries
compared with the control mice, while high dose ASA had no
effect on these lesions (Figure 2A, 2B). The mean size of individual
initial lesions in the carotid artery was not reduced in the NCX
4016 treated mice compared with the control mice (0.01360.009
Table 1. Estimated food/drug intake, body weight and plasma cholesterol levels.
Treatment Food intake Drug intake Final weight Cholesterol (mmol/L)
(g/mouse/day) (mg/kg/day)
(% of initial
weight) Total HDL LDL Triglycerides
0G y
Control chow (n=9) 4.760.7 - 15262 13.561.2 5.460.3 7.161.1 1.860.3
NCX 4016 chow (n=12) 4.760.4 86621 4 1 63
# 15.060.3 5.260.1 9.060.2 1.760.2
ASA high chow (n=12) 4.560.8 457616 11861
# 13.761.2 4.460.2
# 8.660.9 1.660.1
14 Gy
Control chow (n=10) 4.260.5 - 12263 * 12.661.2 4.460.2 7.460.9 1.760.2
NCX 4016 chow (n=11) 4.460.5 82631 2 6 63 * 13.761.2 4.660.2 * 8.560.9 1.560.3
ASA high chow (n=8) 4.160.9 427618 12361 * 14.261.2 5.060.2
# 8.661.1 1.160.1
#*
ASA low chow (n=11) 4.960.8 49621 2 7 62 12.560.5 3.960.1 8.160.4 1.260.1
#
Values are group means 6 SEM. Cholesterol levels were measured in half of the mice after 30 weeks of treatment.
*p,0.05 compared with unirradiated mice with the same chow.
#p,0.05 compared with control chow with the same radiation dose.
doi:10.1371/journal.pone.0012874.t001
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2), while high dose ASA caused an
increased individual initial plaque size (0.02560.012 mm
2;
p=0.001). Neither NCX 4016 nor ASA resulted in a decreased
number or mean individual size of advanced lesions, or a
decreased total plaque burden of the carotid artery (Figure 2C
and D).
In the unirradiated BCA of the aortic arch there was a trend
towards a decreased total number of lesions in the NCX 4016
treated mice compared to the control mice (p=0.052) (Figure 2E),
but no significant decrease in the number of initial lesions
(Figure 2F), or total plaque burden (Figure 2G). High dose ASA
caused a significant decrease in the number of initial lesions in the
BCA, which was not seen in the carotid artery. However, the total
plaque area was increased after high dose ASA (p=0.028)
(Figure 2G). This increase in plaque area was due to an increased
mean size of individual advanced lesions (0.17260.078 and
0.23360.092 mm
2 in control and high dose ASA, respectively).
Plaques in the carotid arteries were scored for the presence of
granulocytes, erythrocyte/iron-containing macrophages and fibrin
deposits. Neither NCX 4016 nor high dose ASA caused phenotypic
changescomparedtothecontrol mice (Table2).Furthermore,these
drugs had no influence on the collagen content of advanced lesions
(Figure 3A). On the other hand, both NCX 4016 and high dose
ASA decreased the collagen content of advanced BCA lesions,
although the percentage collagen is still quite high (Figure 3B).
In conclusion, NCX 4016 significantly reduced the total
number of lesions and the number of initial lesions in the carotid
arteries of unirradiated mice, but was not able to reduce the total
plaque burden. High dose ASA reduced the number of initial
lesions, but increased the plaque area of BCA lesions in
unirradiated mice.
Effect of NCX 4016 and ASA on inflammatory and
thrombotic endothelial markers 4 weeks after irradiation
We examined the carotid arteries of ApoE
2/2 mice sacrificed
at 4 weeks after the start of the irradiation (14 Gy) for the presence
of fatty streaks. In 3 out of 10 mice that received control chow
small fatty streaks were found, while in the mice treated with
NCX 4016 or high dose ASA only 1 out of 10 mice developed
small fatty streaks (not significant). To investigate the effect of
NCX 4016 and ASA on the vascular, inflammatory and
thrombotic response associated with atherosclerosis, we per-
formed quantitative immunohistochemical stainings on carotid
arteries at different locations (below, at and above the bifurcation,
Figure 4A). First, a CD31 staining was performed to determine
the percentage of intact endothelium. This was 88% in the control
group, 94% in the NCX 4016 group (p= 0.013 compared with
control) and 89% in the high dose ASA group. The percentage of
endothelial cells expressing VCAM-1 was significantly lower
above the bifurcation compared with below the bifurcation
(p=0.019) (Figure 4B) and there was a trend for decreased
ICAM-1 expression around and above the bifurcation compared
with below the bifurcation (p=0.06 and p=0.07, respectively)
(Figure 4C). This indicates that there is site-specificity for
expression of these proteins after irradiation. Neither thrombo-
modulin nor eNOS showed different expression levels at the three
positions (Figure 4D and E).
Next, we tested the effect of NCX 4016 and high dose ASA on
the expression levels of these molecules. Treatment with high
dose ASA resulted in a decreased VCAM-1 expression below
and at the bifurcation (p=0.031 and p=0.05, respectively)
compared with mice given control chow. In addition to the
reduction in percentage of endothelial cells expressing VCAM-1,
there was a reduction in the intensity of positive immunostaining
below the bifurcation (p=0.034) (Table 3). There was no effect
of the drugs on the percentage of endothelial cells expressing
ICAM-1 (Figure 4C). However, a slightly increased intensity of
positive immunostaining was seen at the bifurcation of carotid
arteries of mice treated with NCX 4016 compared with control
mice (p=0.017) (Table 3). High dose ASA resulted in a
decreased expression of thrombomodulin at the bifurcation
compared with control mice (p=0.041) (Figure 4D) and also a
decreased intensity of positive immunostaining was seen at the
same position (p=0.041) (Table 3). Neither NCX 4016 nor high
dose ASA had an effect on the expression levels of eNOS
(Figure 4E).
Effect of NCX 4016 and ASA on radiation-induced
atherosclerosis
We next tested whether NCX 4016 or ASA was able to
reduce radiation-induced atherosclerosis. Neither NCX 4016
nor ASA significantly reduced the total number of lesions or the
distribution of lesions in the carotid arteries 30 weeks after start
of the treatment (Figure 5A/B/D). The drugs also had no effect
on the mean size of individual initial lesions (0.07160.040 mm
2
in control), although low dose ASA significantly decreased the
mean size of individual advanced lesions in the carotid artery
(0.09160.070 versus 0.15660.113 mm
2). In the BCA, neither
NCX 4016 nor high dose ASA influenced the number or
distribution of lesions but the total plaque area was significantly
increased in the ASA group (Figure 5G). However, all lesions
in these irradiated BCA arteries were very small and no
differences were seen in the mean size of individual initial
(0.00860.005, 0.01260.012 and 0.01660.006 in control, NCX
4016 and high dose ASA, respectively) or advanced lesions
(0.01460.015, 0.05960.072 and 0.05160.048 in control, NCX
4016 and high dose ASA, respectively) The total plaque areas
were 10-fold less than in the corresponding unirradiated arteries
(Figure 2G).
All carotid lesions of irradiated mice given control chow showed
erythrocyte/iron-containing macrophages compared with 44% of
the unirradiated mice s (p=0.01) (Table 2). Fibrin deposits were
not seen in lesions of the unirradiated control mice, but 60% of the
Figure 1. Platelet aggregation ex vivo in whole blood of
unirradiated and irradiated mice treated with control chow,
NCX 4016 (60 mg/kg/day), low dose (30 mg/kg/day) or high
dose ASA containing chow (300 mg/kg/day). Data represents
group means 6 SEM (n=4–6) * Indicates significant differences
between high dose ASA and control chow (p,0.05 by Mann-Whitney
U test).
doi:10.1371/journal.pone.0012874.g001
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NCX 4016 nor ASA were able to reverse the hemorrhagic
phenotype of the irradiated lesions (Table 2).
Analyses of collagen content of the advanced carotid lesions
showed a decrease in collagen content of irradiated mice
compared with lesions of unirradiated mice receiving control
chow (19% versus 37%; p=0.009) (Figure 3A). This is consistent
with our previous findings and indicates reduced plaque stability in
the irradiated lesions [7,8]. High dose ASA led to a 1.8-fold
increased collagen content compared to control chow (p=0.045),
while low-dose ASA and NCX 4016 had no effect on the collagen
content of irradiated lesions (Figure 3A). The effect of irradiation
on collagen content was more pronounced in the advanced BCA
lesions (3% versus 62% in irradiated and unirradiated lesions;
p=,0.0001). High dose ASA and NCX 4016 were not able to
enhance collagen content of the aortic arch lesions compared with
control chow (Figure 3B).
Discussion
In previous studies we have shown that irradiation of the
carotid arteries of ApoE
2/2 mice accelerated the development of
atherosclerosis and predisposed to the formation of an inflam-
matory, thrombotic plaque phenotype. In the present study we
Figure 2. Morphometric analysis of lesions in unirradiated carotid arteries (A–D) and aortic arches (E-H) of ApoE
2/2 mice treated
with control chow (n=9), NCX 4016 (60 mg/kg/day) (n=12) or high dose ASA containing chow (300 mg/kg/day) (n=12) for 30
weeks. Bar graphs show the mean number of total (A, E), initial (macrophage rich, without a thick fibrous cap) (B, F) and advanced (well-defined,
necrotic/lipid core or thick fibrous cap) (D, H) lesions per animal. Total plaque area is shown in C and G. Data represents group means 6 SEM.
* Indicates significant differences between NCX 4016 or high dose ASA and control chow (p,0.05 by Mann-Whitney U test).
doi:10.1371/journal.pone.0012874.g002
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ASA and NCX 4016 were able to inhibit the development of
radiation-induced atherosclerosis or to reverse the inflammatory
plaque phenotype. NCX 4016 significantly reduced the total
number of atherosclerotic lesions and the number of initial
macrophage-rich lesions in carotid arteries of unirradiated mice,
but these effects were not maintained in irradiated mice. ASA did
not reduce lesion number or size in carotid arteries but did lead
to the formation of collagen-rich stable plaque phenotype in
irradiated mice. High dose ASA reduced the number of initial
lesions in the unirradiated aortic arch, but once again the effect
was not maintained in the irradiated mice. High dose ASA
caused an increased plaque area of the BCA lesions in the aortic
arch and did not lead to a more collagen-rich plaque phenotype
in irradiated mice.
Anti-inflammatory drugs and age-related atherosclerosis
Several pharmacological therapies have been designed to
reduce the development and progression of age-related athero-
sclerosis. ASA, an anti-platelet drug, is used in the prevention of
cardiovascular events in a variety of clinical conditions, such as
myocardial infarction, thrombosis and stroke [14,15]. Its beneficial
effect is not only by blocking platelets’ ability to aggregate, but also
reducing inflammation. In the present study we focused on ASA
and NCX 4016, since these drugs have both anti-inflammatory
and anti-thrombotic activities.
NCX 4016, but not ASA, inhibited the initiation of atheroscle-
rotic lesions in carotid arteries of unirradiated ApoE
2/2 mice.
There were significantly fewer total lesions compared with age-
matched controls and a marked reduction in the initial lesions
without a fibrous cap. However, this did not result in a reduced
total plaque area. In hypercholesterolemic LDLR
2/2 mice,
treatment with NCX 4016 significantly reduced atherosclerotic
lesion area in the carotid artery after 12 weeks of treatment, while
ASA had no effect on the lesion size [21]. In an injury-induced
neointima formation model it was also found that NCX 4016, but
not ASA, reduced neointimal expansion [20,22] and this reduction
was associated with a marked deficit in inflammatory cells
recruited to the injured vessel [20]. The protective effect of
NCX 4016 was in part due to the vasoactive action of nitric oxide
(NO) released from the molecule, since the dose of ASA used had
the equivalent ASA concentration as the NCX 4016 drug dose
used. NO is also involved in the control of several pathophysio-
logical responses, including inflammatory cell adhesion, vascular
reactivity, endothelial permeability and regulation of smooth
muscle cell proliferation [23,24].
In the aortic arch we saw a decrease in the number of initial
lesions in mice treated with high dose ASA compared with age-
matched controls, but the total plaque area was increased after a
30 week follow-up. This is consistent with a previous report
where low dose ASA inhibited the initiation of lesions in the
artery of ApoE
2/2 mice on a high cholesterol diet, but long term
administration eventually stimulated lesion growth [25]. In our
study ASA decreased the collagen content of advanced BCA
lesions of the aortic arch in unirradiated mice. This contrasts
with a study in LDLR
2/2 mice that showed that aspirin
significantly reduced vascular inflammation in aortic atheroscle-
rotic lesions of unirradiated mice and increased the amount of
collagen in the atherosclerotic plaques, thereby increasing plaque
stability [26].
Anti-inflammatory drugs and endothelial cell damage
Radiation has been shown to upregulate endothelial cell
adhesion molecules, such as ICAM-1, VCAM-1 and P-selectin,
Figure 3. Collagen content of advanced lesions in carotid
arteries (A) and aortic arches (brachiocephalic artery) (B) of
unirradiated and irradiated male ApoE2/2 mice treated with
control chow, NCX 4016 (60 mg/kg/day), low dose (30 mg/kg/
day) or high dose ASA (300 mg/kg/day) containing chow for 30
weeks. Data represents group means 6 SEM. * p,0.05 compared with
unirradiated mice with the same chow,
# p,0.05 compared with
control chow (Mann-Whitney U test).
doi:10.1371/journal.pone.0012874.g003
Table 2. Semi-quantitative analysis of thrombotic features in
unirradiated and irradiated carotid arteries of ApoE
2/2 mice
treated with control chow, NCX 4016 (60 mg/kg/day), low
dose ASA (30 mg/kg/day) or high dose ASA (300 mg/kg/day)
for 30 weeks.
Treatment Granulocytes
Fe/Macr, Ery/
Macr Fibrin
0G y
Control chow 4/9 4/9 0/9
NCX 4016 chow 2/9 4/9 2/9
ASA high chow 8/12 5/12 1/12
14 Gy
Control chow 8/10 10/10* 6/10*
NCX 4016 chow 6/11 9/11 6/11
ASA high chow 6/8 6/8 3/8
ASA low chow 11/11 10/11 5/11
*p,0.05 compared with unirradiated mice with the same chow.
doi:10.1371/journal.pone.0012874.t002
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High dose ASA reduced the expression of VCAM-1 in irradiated
carotid arteries, however neither NCX 4016 nor ASA had any
significant effect on ICAM-1 expression in our studies. Previously
published in vitro studies have shown that ASA is able to inhibit
induction of VCAM-1 in TNF stimulated HUVECs [27].
However, in vivo studies in arteries of hypercholesterolemic
rabbits or ApoE
2/2 mice showed either no change in expression
of VCAM-1, or only a small reduction [25,28]. No previous
publications have reported on the effects of anti-inflammatory
drugs in irradiated arteries of hypercholesterolemic animals.
Thrombomodulin controls the balance between the pro-
coagulant activities of thrombin (fibrin generation, platelet activa-
tion) and anticoagulant activity, and determines a condition of
either normal homeostasis (high expression of TM) or vessel
pathology (low expression of TM). Clinical studies and experiments
in animal models have demonstrated that exposure of normal tissue
to ionizing radiation is associated with rapid and sustained loss of
thrombomodulin in microvascular endothelial cells [29,30]. In our
model of irradiated carotid arteries, a reduction of thrombomodulin
expression around the bifurcation was seen after treatment with
high dose ASA. This might be expected to counteract the ASA-
induced reduction in VCAM-1 expression. NCX 4016 did not have
this effect on thrombomodulin.
Overall, we conclude from the immunohistochemical stainings
that neither NCX 4016 nor high dose ASA shifted the balance of
pro- and anti-inflammatory/thrombotic molecules at 4 weeks after
irradiation.
Figure 4. Immunohistochemical stainings of inflammatory and thrombotic markers. A) VCAM-1 and ICAM-1 expression of carotid arteries
with adjacent CD31 staining. Expression levels of VCAM-1 (B), ICAM-1 (C), thrombomodulin (D) and eNOS (E) in endothelial cells of carotid arteries of
irradiated ApoE
2/2 treated with control chow, NCX 4016 (60 mg/kg/day) or high dose ASA (300 mg/kg/day) containing chow. Bar graphs show the
mean expression levels at three positions in the carotid artery: 21; below the bifurcation, 0; at the bifurcation, 1; above the bifurcation and are
corrected for the percentage of intact endothelium detected with CD31. Data represents group means 6 SEM (n=10) * Indicates significant
differences between high dose ASA and control chow at the same position and
# indicates significant difference between position -1 and 1(p,0.05
by Mann-Whitney U test).
doi:10.1371/journal.pone.0012874.g004
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atherosclerosis
In previous studies, we have shown that irradiation of the
carotid arteries of ApoE
2/2 mice accelerated the development of
atherosclerosis and predisposed to the formation of an inflamma-
tory, thrombotic plaque phenotype [7,8]. However, the effect of
irradiation on the aortic arch is different compared to the carotid
lesions. Although we see a similar (two-fold) increase in the
number of initial lesions in both the aortic arch region and carotid
arteries, plaque size of the BCA lesion was strikingly smaller in the
irradiated animals. Vascular site-specific effects on the develop-
ment of atherosclerosis is a frequently reported phenomenon [31].
In the context of irradiation, Schiller and colleagues also reported
site-specific differences in lesion development after 10 Gy whole
body irradiation and subsequent bone marrow transplantation
(BMT). In this study, thoracic aortic lesion area decreased, while
lesion area in the aortic valve region increased after BMT [32]. It
is assumed that variation in lesion development at different sites is
sensitive to several parameters, such as genetic background,
immune status, gender, hemodynamic factors and differences in
endothelial or smooth muscle cell gene expression [31,33]. In the
current study, site specificity was observed in both the effect of the
intervention (protecting effect of NCX 4016 in carotid arteries of
unirradiated animals, while ASA stabilized plaque development in
the irradiated animals) and the effect of irradiation itself in the
carotid and aortic arch region. The underlying mechanisms
remain to be determined.
Conclusions
Although modest benefits were obtained by NCX 4016 in the
unirradiated animals, in terms of inhibition of carotid lesions, the
drug was not effective at inhibiting lesion development in the
irradiated animals. Irradiation could be too strong a challenge to
be counteracted by NO. Irradiation causes chronic oxidative stress
[34] which may reduce the protective effect of pharmacologically
released NO. The effects of ASA on development of atheroscle-
rosis were site-dependent. ASA reduced the number of initial
lesions in the unirradiated aortic arch but increased the total
plaque burden. The collagen content of advanced carotid lesions
increased in irradiated mice treated with high dose ASA compared
to mice treated with control chow, indicating that ASA
‘‘stabilized’’ the plaques reversed the radiation-induced reduction
in collagen seen in both the current study and our previous studies
[7,8]. However, this effect was not seen in the BCA.
The effects of radiation-induced atherosclerosis could not be
circumvented by these anti-inflammatory and anti-thrombotic
therapies, suggesting other underlying mechanistic pathways
compared to age-related atherosclerosis.
Materials and Methods
Ethics statement
Mice were housed according to guidelines of the Netherlands
Cancer Institute, and procedures were carried out in compliance
with standards for use of laboratory animals. Animal experiments
performed in this manuscript have been approved by the animal
experimental committee of the Netherlands Cancer Institute
(DEC-consult).
Experimental design and irradiation
ApoE
2/2 mice on a C57BL/6J background were bred in
isolator cages at the breeding facility of the Netherlands Cancer
Institute. After weaning, at 3 weeks of age, male mice were housed
in filter-top cages and given free access to standardized mouse
chow (3.7% fat, RM1 (E) SQC, SDS, London, U.K.) and acidified
drinking water. NCX 4016 (3-(nitrooxymethyl)phenyl 2-(acety-
loxy) benzoate) was provided by NicOx SA, France and ASA was
purchased from Sigma. At the age of 9–10 weeks the mice were
given NCX 4016 (555 mg/kg food) or ASA at low or high doses
(278 or 2,778 mg/kg food) in the chow. Control mice received the
same chow without any drugs. The food consumption was
recorded throughout the follow-up period and used to estimate
the daily drug intake per mouse. This indicated daily doses of
.60 mg/kg NCX 4016, .30 mg/kg ASA or .300 mg/kg ASA.
The final doses of ASA and NCX 4016 were based on published
studies in mice and rats on cardiovascular endpoints [22,35–37].
The mice received the chow one week before irradiation and
continuously throughout the experiment. For the short term
experiments (4 week follow-up) all mice received 14 Gy irradiation
to the neck region and for the long term experiments half of the
mice received 14 Gy irradiation and the other half received sham
irradiation (0 Gy) and the mice were sacrificed 30 weeks after
irradiation.
Irradiation was in a dorso-ventral direction, with 250-kV X-
rays, operating at 12 mA and filtered with 0.6 mm of copper. The
field size was 20615 mm, encompassing both carotid arteries, the
aortic arch, and basal portion of the heart, but with the lung
outside the 100% iso-dose region. The mice had a body weight of
20-30 g to ensure correct positioning of the carotid arteries within
the irradiation field.
Platelet aggregation
In half of the mice per group, platelet aggregation was measured
immediately prior to sacrifice, using a two-channel whole-blood
aggregometer (CH 590-2D with Aggrolink, Chronolog Corp.,
Havertown, PA). Blood samples were collected via heart puncture
under anesthesia and diluted with 0.38% citrate buffer (9:1 v/v).
All analyses were performed within 25 min from blood sampling.
A 500 ml sample of citrated blood was added to the aggregometer
cuvette containing 500 ml saline and stirred at 37uC. Arachidonic
acid (Chonolog, final concentration 0.1 mM) was used to stimulate
aggregation. Changes in electrical impedance were monitored for
Table 3. Intensity data of VCAM-1, ICAM-1, thrombomodulin
and eNOS quantitative immunohistochemical stainings in
carotid arteries of irradiated ApoE
2/2 mice treated with
control chow, NCX 4016 (60 mg/kg/day) or high dose ASA
(300 mg/kg/day) containing chow for 4 weeks.
Treatment Position Intensity
VCAM-1 ICAM-1 TM eNOS
Control chow 211 9 4 63 20062 174642 0 5 63
01 9 4 63 20261 173632 0 7 63
11 9 8 62 20361 171642 0 4 62
NCX 4016 chow212 0 1 63 19662 184652 0 6 62
01 9 8 62 19862 * 180662 0 5 62
12 0 2 62 20161 183652 0 7 62
ASA high chow 212 0 3 63 * 19862 181642 0 2 62
02 0 1 63 20262 18364 * 20562
12 0 4 62 20562 181652 0 3 62
Average 6 SEM (n=10).
*compared with control chow at the same position (p,0.05).
doi:10.1371/journal.pone.0012874.t003
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resistance.
Blood sampling and analysis
Half of the mice were sacrificed after overnight fasting, and
blood samples were taken by cardiac aspiration. Blood samples
were collected in EDTA tubes (Becton Dickinson, Alphen aan den
Rijn, the Netherlands) and centrifuged at 3500 rpm for 15 minutes
at 4uC. Plasma samples were frozen at 270uC. Plasma cholesterol
and triglyceride levels were determined by standard colorimetric
enzyme assays (Cobas integra 400, Roche Diagnostics, Almere,
The Netherlands).
Tissue handling
Short-term experiments (4 weeks after irradiation).
Directly after sacrifice and blood sampling, the arterial system
was perfused with 0.1 mg/ml sodium-nitroprusside in
phosphate-buffered saline (PBS) under standard pressure
(100 mm Hg) for 3 minutes. The carotid arteries were excised,
stained with eosine and separately embedded between 2 pieces of
liver tissue to provide rigidity for the fragile arteries during
sectioning. The preparation was rapidly frozen on dry ice and
stored at 270uC.
Long-term experiments (30 weeks after irradiation).
Directly after sacrifice and blood sampling, the arterial system
Figure 5. Morphometric analysis of lesions in irradiated carotid arteries (A–D) and aortic arches (E-H) of ApoE
2/2 mice treated with
control chow (n=10), NCX 4016 (60 mg/kg/day) (n=11), low dose (30 mg/kg/day) (n=11) or high dose ASA containing chow
(300 mg/kg/day) (n=8) for 30 weeks. Bar graphs show the mean number of total (A, E), initial (macrophage rich, without a thick fibrous cap) (B,
F) and advanced (well-defined, necrotic/lipid core or thick fibrous cap) (D, H) lesions per animal. Total plaque area is shown in C and G. Data
represents group means 6 SEM. * Indicates significant differences between high dose ASA and control chow (p,0.05 by Mann-Whitney U test).
doi:10.1371/journal.pone.0012874.g005
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standard pressure (100 mm Hg) for 3 minutes, followed by 1%
paraformaldehyde fixative (3 minutes). The cervical, thoracic and
abdominal arterial tree and the heart were excised and the entire
preparation was attached to a cork sheet and fixed for 24 hours in
1% paraformaldehyde before transfer to 70% alcohol. The lungs
were excised separately. The aortic arch, carotid arteries,
descending thoracic aorta, renal arteries, heart and lungs were
embedded in paraffin.
Morphometric analysis of plaque
Short-term experiments (cryostat sections). Serial cross-
sections of 7 mm were collected on 20 glass microscope slides,
which gave 140 mm between adjacent cryostat sections on one
slide as described before [8]. One slide was stained with
hematoxylin and eosin (H&E) and the section at the site of the
bifurcation (position 0) and one section above (position 1) and
below the bifurcation (position -1) was scored to identify the
presence of fatty streaks.
Long-term experiments (paraffin embedded arteries).
For the quantitative analysis of plaque area and number,
approximately 35 longitudinal, serial sections of 4 mm were
made from each carotid artery and the aortic arch. Every fifth
section (20 mm apart) was stained with H&E. Plaque area was
measured on four of these sections artery, selected to cover the
central part of the lesion, and the average of these measurements
was recorded per lesion. Total numbers and areas of lesions in left
and right carotid artery were calculated per mouse. In the aortic
arch the total number of lesions was determined in the complete
aortic arch and the plaque area was measured only in the
brachiocephalic artery (BCA). All plaques were categorized as
initial lesion (macrophage rich, without a thick fibrous cap) or
advanced (well-defined, necrotic/lipid core or thick fibrous cap),
using a modified American Heart Association classification scheme
[38,39]. The sections were also examined for the presence of
collagen (Sirius Red staining), fibrin (Martius-scarlet-blue
trichrome staining), iron-containing macrophages (Perl staining)
and granulocytes (H&E and confirmed with a Ly6G staining).
Morphometric parameters (plaque area and collagen content)
were analyzed using a microscope coupled to a computerized
morphometry system (Leica Qwin V3, Leica, The Netherlands).
The relative collagen content was determined by dividing the
positive collagen area by the individual plaque area. All
measurements were made, without knowledge of the treatment
group, by one investigator.
Immunohistochemistry
Cryostat sections of the carotid arteries were air-dried and the
slides were fixed for 10 min in acetone at 220uC (except for
CD31). Endogenous peroxidase activity was blocked with 0.3%
hydrogen peroxide in methanol for 30 min. Endogenous biotin
was blocked with the avidin/biotin blocking kit (DAKO, ITK
Diagnostics BV, Uithoorn, The Netherlands). After blocking of
nonspecific binding sites with protein block serum free (DAKO),
slides were incubated overnight with primary antibodies at 4uC.
After rinsing with PBS, the slides were incubated with the
biotinylated secondary antibodies rabbit anti-rat IgG (45 min),
rabbit anti-hamster IgG (45 min) or swine anti-rabbit IgG
(30 min). All antibodies were purchased from DAKO. Antibody
reactivity was detected using HRP (horse radish peroxidase)-
conjugated biotinavidin complexes (Vector Laboratories, Burlin-
game, CA) and developed with DAB solution (Sigma). Primary
antibodies comprised: rat anti-mouse CD31 (Platelet Endothelial
Cell Adhesion Molecule, PECAM-1, Becton Dickinson, Alphen
aan de Rijn, The Netherlands) diluted 1:50, hamster anti-mouse
CD54 (ICAM-1, Becton Dickinson) diluted 1:50, rat anti-mouse
CD106 (VCAM-1, Becton Dickinson) diluted 1:25, rabbit anti-
mouse thrombomodulin (American Diagnostica, Greenwich, CT)
diluted 1:200 and rabbit anti-mouse eNOS (endothelial nitric
oxide synthase, Santa Cruz Tech., Santa Cruz, CA) diluted
1:200. Primary and secondary antibodies were diluted in 1%
BSA/PBS. As a control for background staining, control slides
were treated in the same manner, except 1% BSA/PBS was
substituted for the primary antibodies. Within one experiment all
sections were processed identically, at the same time with
precisely the same incubation times for the primary and
secondary antibody and DAB. Therefore, all differences between
the treatments are ultimately due to DAB identification of the
relevant protein.
Quantitative analysis of the immunohistochemistry
The amount and intensity of CD31, ICAM-1, VCAM-1,
thrombomodulin and eNOS staining in the endothelium of the
carotid arteries at three positions around the bifurcation (21, 0
and 1) were quantitatively analyzed. Each tissue section was
photographed and analyzed using a microscope (206objective)
coupled to a computerized morphometry system (Leica Qwin
V3, Leica). The endothelial cell layer was determined as
representing the inner most layer of the vessel wall automatically
detected from the lumen contour. The immunopositive signal in
the endothelial cell layer was measured by setting a threshold on
the RGB monochromatic channels as determined by the
observer. The threshold values ofe a c hs t a i n i n gw e r et h e nh e l d
constant in the analysis of all images. The relative immunopo-
sitive staining was calculated as the sum of the immunopositive
area divided by the sum of the total endothelial area (area(x)).
The area of CD31 expression was considered as a total area of
intact endothelium (area(CD31)). The average optical density
(OD) of these areas was automatically calculated (0–255: 0=
dense amount and 255= none). The area of ICAM-1, VCAM-
1, thrombomodulin and eNOS expression indicates the
percentage of activated endothelial cells calculated as: area(x)/
area (CD31) x 100%.
Statistics
Quantitative morphometric analyses of plaques and quantitative
immunohistochemical analysis were expressed as means 6 SEM
and irradiated and unirradiated groups were compared using a
non-parametric Mann-Whitney U-test. Data for assessment of
fatty streak formation, thrombotic and inflammatory plaque
characteristics were expressed as incidence of carotid arteries
containing lesions with these phenotypes, and the groups were
compared using the Fisher’s Exact test. Group differences were
considered statistically significant at p,0.05.
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